NCT00740532View on ClinicalTrials.gov

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

August 31, 2010

Conditions
Breast Cancer
Interventions
GENETIC

Gene mutation analyses and FISH

FISH and mutation analyses of multiple genes

Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT00740532 - Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients | Biotech Hunter | Biotech Hunter